Sign Out
Teratogenic Effects.
Pregnancy: Category C: Since there are no adequate and well-controlled studies in pregnant woman, MOSI should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.
Nursing Mothers: Moxifloxacin has not been measured in human milk, although it can be presumed to be excreted in human milk. Caution should be exercise when MOSI is administered to a nursing mother.
